Hollywood, FL (January 24, 2020) – Thomas O. McNamara, MD, received the 2020 ISET Career Achievement award on Friday, January 24th, as presented by James Benenati, MD.
Hollywood, FL (January 24, 2020) – Thomas O. McNamara, MD, received the 2020 ISET Career Achievement award on Friday, January 24th, as presented by James Benenati, MD.
Hollywood, FL (January 24, 2020) – Selected to present this year’s Tegtmeyer Lecture at the International Symposium on Endovascular Therapy (ISET) was Ziv Haskal, MD, Professor/Fellowship Director of the Division of Interventional Radiology...
Hollywood, FL (January 24, 2020) – Selected to present this year’s Tegtmeyer Lecture at the International Symposium on Endovascular Therapy (ISET) was Ziv Haskal, MD, Professor/Fellowship Director of the Division of Interventional Radiology...
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
The Stellarex drug-coated balloon (DCB) (Philips) showed “excellent” safety and effectiveness in a real-world population of patients with complex peripheral artery disease (PAD).
Hollywood, FL (January 22, 2020) -- The International Symposium on Endovascular Therapy (ISET) 2020 started its first day with a provocative and informative session on the business of healthcare.
Hollywood, FL (January 22, 2020) -- The International Symposium on Endovascular Therapy (ISET) 2020 started its first day with a provocative and informative session on the business of healthcare.
The 9th annual Amputation Prevention Symposium (AMP) kicked off Wednesday at the Hilton Chicago with the Critical Limb Ischemia (CLI) in 2019 #LeaveYourSpecialtyatTheDoor session. Founder and Course Director Jihad Mustapha, MD, of Advanced...
The 9th annual Amputation Prevention Symposium (AMP) kicked off Wednesday at the Hilton Chicago with the Critical Limb Ischemia (CLI) in 2019 #LeaveYourSpecialtyatTheDoor session. Founder and Course Director Jihad Mustapha, MD, of Advanced...
We have been using the R2P Destination Slender (Terumo) and the attendant equipment in over 2 dozen cases during the last 6 to 8 months. We present three case examples to illustrate the promise of these sheaths, wires, and balloons, as well...
We have been using the R2P Destination Slender (Terumo) and the attendant equipment in over 2 dozen cases during the last 6 to 8 months. We present three case examples to illustrate the promise of these sheaths, wires, and balloons, as well...
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)
Cardiovascular...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System
LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness
Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...